CSPC Other Assets vs Net Receivables Analysis

300765 Stock

28.51 0.27 0.94%

CSPC Innovation financial indicator trend analysis is way more than just evaluating CSPC Innovation Phar prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CSPC Innovation Phar is a good investment. Please check the relationship between CSPC Innovation Other Assets and its Net Receivables accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CSPC Innovation Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Other Assets vs Net Receivables

Other Assets vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CSPC Innovation Phar Other Assets account and Net Receivables. At this time, the significance of the direction appears to have very strong relationship.

The correlation between CSPC Innovation's Other Assets and Net Receivables is 0.89. Overlapping area represents the amount of variation of Other Assets that can explain the historical movement of Net Receivables in the same time period over historical financial statements of CSPC Innovation Pharmaceutical, assuming nothing else is changed. The correlation between historical values of CSPC Innovation's Other Assets and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Assets of CSPC Innovation Pharmaceutical are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Other Assets i.e., CSPC Innovation's Other Assets and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.89

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Other Assets

Net Receivables

Most indicators from CSPC Innovation's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CSPC Innovation Phar current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CSPC Innovation Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 295.7 M, whereas Tax Provision is forecasted to decline to about 82.2 M.

	2021	2022	2023	2024 (projected)
Gross Profit	685.9M	1.1B	1.1B	806.6M
Total Revenue	1.4B	2.6B	2.5B	1.7B

Gross Profit Total Revenue

CSPC Innovation fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Net Debt	Long Term Debt	Common Stock Shares Outstanding	Net Invested Capital	Short Long Term Debt
Total Assets		0.0	0.68	1.0	-0.49	0.99	0.99	0.9	0.86	0.98	0.17	0.93	0.77	-0.07	0.87	-0.06	0.51	0.92	-0.84	0.89	0.98	-0.46	-0.83	0.89	1.0	-0.83
Other Current Liab	0.0		0.18	-0.01	0.5	0.09	-0.01	0.09	-0.37	0.03	-0.04	0.03	0.27	0.21	0.14	0.64	0.1	-0.2	0.07	-0.22	-0.01	0.68	-0.18	-0.38	-0.05	-0.17
Total Current Liabilities	0.68	0.18		0.65	-0.18	0.64	0.67	0.91	0.64	0.66	-0.47	0.64	0.69	-0.09	0.66	-0.18	0.84	0.64	-0.53	0.62	0.7	-0.35	-0.42	0.6	0.68	-0.42
Total Stockholder Equity	1.0	-0.01	0.65		-0.5	0.99	0.99	0.89	0.85	0.98	0.2	0.93	0.77	-0.08	0.87	-0.04	0.46	0.92	-0.85	0.9	0.98	-0.46	-0.84	0.89	1.0	-0.84
Other Liab	-0.49	0.5	-0.18	-0.5		-0.46	-0.44	-0.34	-0.73	-0.45	-0.27	-0.32	-0.18	0.28	-0.33	0.46	-0.03	-0.7	0.61	-0.7	-0.4	0.76	0.23	-0.53	-0.54	0.24
Net Tangible Assets	0.99	0.09	0.64	0.99	-0.46		0.98	0.88	0.81	0.96	0.22	0.94	0.8	-0.07	0.9	0.08	0.41	0.89	-0.87	0.88	0.97	-0.38	-0.86	0.83	0.98	-0.86
Retained Earnings	0.99	-0.01	0.67	0.99	-0.44	0.98		0.91	0.86	0.99	0.18	0.96	0.8	-0.01	0.9	0.0	0.49	0.91	-0.86	0.91	0.99	-0.46	-0.84	0.87	0.99	-0.84
Accounts Payable	0.9	0.09	0.91	0.89	-0.34	0.88	0.91		0.81	0.88	-0.18	0.88	0.82	-0.04	0.88	-0.04	0.69	0.83	-0.77	0.84	0.93	-0.42	-0.66	0.79	0.9	-0.66
Cash	0.86	-0.37	0.64	0.85	-0.73	0.81	0.86	0.81		0.86	0.08	0.79	0.63	-0.12	0.74	-0.35	0.5	0.97	-0.85	0.96	0.84	-0.83	-0.63	0.85	0.88	-0.64
Non Current Assets Total	0.98	0.03	0.66	0.98	-0.45	0.96	0.99	0.88	0.86		0.23	0.92	0.75	0.02	0.84	-0.05	0.55	0.91	-0.81	0.89	0.95	-0.46	-0.83	0.84	0.97	-0.84
Non Currrent Assets Other	0.17	-0.04	-0.47	0.2	-0.27	0.22	0.18	-0.18	0.08	0.23		0.04	-0.22	-0.14	-0.03	0.15	-0.42	0.1	-0.12	0.16	0.08	0.08	-0.31	0.06	0.18	-0.31
Other Assets	0.93	0.03	0.64	0.93	-0.32	0.94	0.96	0.88	0.79	0.92	0.04		0.89	0.16	0.96	0.17	0.43	0.86	-0.87	0.85	0.98	-0.41	-0.82	0.8	0.92	-0.83
Net Receivables	0.77	0.27	0.69	0.77	-0.18	0.8	0.8	0.82	0.63	0.75	-0.22	0.89		0.13	0.95	0.33	0.38	0.75	-0.85	0.72	0.83	-0.32	-0.79	0.55	0.75	-0.79
Non Current Liabilities Total	-0.07	0.21	-0.09	-0.08	0.28	-0.07	-0.01	-0.04	-0.12	0.02	-0.14	0.16	0.13		0.09	0.33	0.14	-0.12	0.09	-0.1	0.01	0.16	0.14	-0.16	-0.1	0.15
Inventory	0.87	0.14	0.66	0.87	-0.33	0.9	0.9	0.88	0.74	0.84	-0.03	0.96	0.95	0.09		0.31	0.33	0.83	-0.93	0.85	0.93	-0.37	-0.8	0.67	0.86	-0.8
Other Current Assets	-0.06	0.64	-0.18	-0.04	0.46	0.08	0.0	-0.04	-0.35	-0.05	0.15	0.17	0.33	0.33	0.31		-0.43	-0.21	-0.14	-0.12	0.05	0.6	-0.24	-0.38	-0.09	-0.22
Total Liab	0.51	0.1	0.84	0.46	-0.03	0.41	0.49	0.69	0.5	0.55	-0.42	0.43	0.38	0.14	0.33	-0.43		0.45	-0.18	0.39	0.48	-0.31	-0.2	0.49	0.48	-0.21
Total Current Assets	0.92	-0.2	0.64	0.92	-0.7	0.89	0.91	0.83	0.97	0.91	0.1	0.86	0.75	-0.12	0.83	-0.21	0.45		-0.92	0.97	0.89	-0.75	-0.76	0.84	0.93	-0.77
Intangible Assets	-0.84	0.07	-0.53	-0.85	0.61	-0.87	-0.86	-0.77	-0.85	-0.81	-0.12	-0.87	-0.85	0.09	-0.93	-0.14	-0.18	-0.92		-0.93	-0.86	0.6	0.8	-0.68	-0.86	0.81
Common Stock	0.89	-0.22	0.62	0.9	-0.7	0.88	0.91	0.84	0.96	0.89	0.16	0.85	0.72	-0.1	0.85	-0.12	0.39	0.97	-0.93		0.89	-0.7	-0.7	0.8	0.92	-0.71
Property Plant Equipment	0.98	-0.01	0.7	0.98	-0.4	0.97	0.99	0.93	0.84	0.95	0.08	0.98	0.83	0.01	0.93	0.05	0.48	0.89	-0.86	0.89		-0.44	-0.81	0.87	0.97	-0.81
Net Debt	-0.46	0.68	-0.35	-0.46	0.76	-0.38	-0.46	-0.42	-0.83	-0.46	0.08	-0.41	-0.32	0.16	-0.37	0.6	-0.31	-0.75	0.6	-0.7	-0.44		0.29	-0.6	-0.5	0.31
Long Term Debt	-0.83	-0.18	-0.42	-0.84	0.23	-0.86	-0.84	-0.66	-0.63	-0.83	-0.31	-0.82	-0.79	0.14	-0.8	-0.24	-0.2	-0.76	0.8	-0.7	-0.81	0.29		-0.61	-0.81	1.0
Common Stock Shares Outstanding	0.89	-0.38	0.6	0.89	-0.53	0.83	0.87	0.79	0.85	0.84	0.06	0.8	0.55	-0.16	0.67	-0.38	0.49	0.84	-0.68	0.8	0.87	-0.6	-0.61		0.9	-0.62
Net Invested Capital	1.0	-0.05	0.68	1.0	-0.54	0.98	0.99	0.9	0.88	0.97	0.18	0.92	0.75	-0.1	0.86	-0.09	0.48	0.93	-0.86	0.92	0.97	-0.5	-0.81	0.9		-0.81
Short Long Term Debt	-0.83	-0.17	-0.42	-0.84	0.24	-0.86	-0.84	-0.66	-0.64	-0.84	-0.31	-0.83	-0.79	0.15	-0.8	-0.22	-0.21	-0.77	0.81	-0.71	-0.81	0.31	1.0	-0.62	-0.81

Click cells to compare fundamentals

CSPC Innovation Account Relationship Matchups

CSPC Innovation fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.9B	3.0B	3.2B	4.6B	5.6B	3.1B
Other Current Liab	289.4M	145.0M	224.1M	337.6M	2.3M	2.1M
Total Current Liabilities	400.8M	234.2M	408.6M	582.8M	510.8M	429.1M
Total Stockholder Equity	2.4B	2.7B	3.0B	3.9B	5.1B	2.7B
Other Liab	36.3M	33.8M	34.9M	37.3M	33.5M	29.6M
Net Tangible Assets	2.3B	2.6B	3.2B	3.9B	4.5B	2.2B
Retained Earnings	1.1B	1.4B	1.5B	2.2B	2.6B	1.5B
Accounts Payable	92.7M	64.2M	129.2M	178.7M	173.7M	116.1M
Cash	475.1M	1.1B	1.2B	2.2B	3.4B	3.6B
Non Current Assets Total	915.4M	1.0B	907.8M	1.4B	1.4B	1.1B
Non Currrent Assets Other	7.0M	736.9M	14.7M	15.9M	20.6M	19.6M
Other Assets	19.9M	19.8M	31.6M	34.8M	40.0M	24.8M
Net Receivables	351.2M	146.3M	510.3M	481.4M	392.4M	358.9M
Non Current Liabilities Total	36.3M	33.8M	34.4M	57.1M	34.1M	36.2M
Inventory	124.2M	111.0M	262.0M	238.1M	223.7M	174.5M
Other Current Assets	26.3M	35.6M	56.9M	38.5M	10.9M	10.3M
Total Liab	437.1M	268.0M	265.4M	639.8M	545.0M	454.5M
Total Current Assets	1.9B	1.9B	2.5B	3.2B	4.2B	4.4B
Intangible Assets	57.6M	55.2M	42.4M	50.4M	48.0M	44.0M
Common Stock	200M	420M	546M	618.9M	711.8M	747.4M
Property Plant Equipment	678.2M	727.5M	926.4M	1.1B	1.2B	803.5M
Net Invested Capital	2.4B	2.7B	3.0B	4.0B	5.1B	3.0B
Net Working Capital	1.5B	1.7B	2.1B	2.6B	3.7B	1.9B
Capital Stock	200M	420M	546M	618.9M	1.2B	1.2B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in CSPC Stock

Balance Sheet is a snapshot of the financial position of CSPC Innovation Phar at a specified time, usually calculated after every quarter, six months, or one year. CSPC Innovation Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of CSPC Innovation and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CSPC currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CSPC Other Assets vs Net Receivables Analysis

Other Assets vs Net Receivables

Other Assets vs Net Receivables Correlation Analysis

Correlation Coefficient

Other Assets

Net Receivables

CSPC Innovation fundamental ratios Correlations

CSPC Innovation Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CSPC Innovation fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in CSPC Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Short Long Term Debt	+ 1.0	Long Term Debt
Net Tangible Assets	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Assets

Common Stock	- 0.93	Intangible Assets
Intangible Assets	- 0.93	Inventory
Intangible Assets	- 0.92	Total Current Assets
Intangible Assets	- 0.87	Other Assets
Intangible Assets	- 0.87	Net Tangible Assets
Net Invested Capital	- 0.86	Intangible Assets